Inventor · disambiguated record
Paul Angell
Also filed as: ANGELL PAUL · ANGELL PAUL T · ANGELL PAUL TIMOTHY
21 granted patents·3 pending applications·155 citations·filing 1990–2023
95Inventor score
Top patents by PatentIndex Score
24 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0297US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 0397US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 0497US9862709B2Processes for making compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2015·Granted Jan 9, 2018·16 cites·36 claims
- 0597US9035053B2Processes for making compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted May 19, 2015·21 cites·24 claims
- 0693US12122788B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Oct 22, 2024·1 cites·21 claims
- 0793US8846686B2Compounds useful as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2012·Granted Sep 30, 2014·16 cites·47 claims
- 0892US11434201B2Processes for preparing pyrrolidine compoundsVERTEX PHARMA·Filed 2018·Granted Sep 6, 2022·6 cites·22 claims
- 0992US7772252B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 1090US10208027B2Processes for preparing ATR inhibitorsVERTEX PHARMA·Filed 2017·Granted Feb 19, 2019·3 cites·20 claims
- 1187US11465985B2Processes for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2018·Granted Oct 11, 2022·6 cites·8 claims
- 1287US10822331B2Processes for preparing ATR inhibitorsVERTEX PHARMA·Filed 2018·Granted Nov 3, 2020·2 cites·35 claims
- 1381US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 1476US12415798B2Processes for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Sep 16, 2025·0 cites·5 claims
- 1569US7186724B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2004·Granted Mar 6, 2007·4 cites·40 claims
- 1661US2025320226A1Methods of preparing and crystalline forms of (6a,12a)-17-amino-12-methyl-6,15-bis(trifluoromethyl)-13,19-dioxa-3,4,18-triazatricyclo[12.3.1.12,5]nonadeca-1(18),2,4,14,16-pentaen-6-olVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1757US7521445B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2007·Granted Apr 21, 2009·0 cites·19 claims
- 1854US5093501AIntermediates in a process for the preparation of castanospermineMERRELL DOW PHARMA·Filed 1991·Granted Mar 3, 1992·5 cites·3 claims
- 1948US5874627AProcess for preparing polyamine derivatives and intermediates thereofMERRELL PHARMA INC·Filed 1997·Granted Feb 23, 1999·3 cites·6 claims
- 2048US2011040105A1Processes useful for the synthesis of (r)-1--2-methyl-pyrrolidineARENA PHARM INC·Filed 2009·Application pending·0 cites
- 2144US5066807AProcess for the preparation of castanospermineMERRELL DOW PHARMA·Filed 1990·Granted Nov 19, 1991·7 cites·4 claims
- 2244US2006004211A1Preparation of 4-substituted-2-buten-4-olides from mucohalic acidsWARNER LAMBERT CO·Filed 2005·Application pending·0 cites
- 2334USD498805STransparent bridge for a game racketDUNLOP SLAZENGER GROUP LTD·Filed 2003·Granted Nov 23, 2004·2 cites·1 claims
- 2433US5756739AProcess for preparing polyamine derivative and intermediates thereofMERRELL PHARMA INC·Filed 1997·Granted May 26, 1998·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Paul Angell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →